Ashit Trivedi Selected Research

Rosuvastatin Calcium (Crestor)

11/2021

Evaluation of drug-drug interaction potential between omecamtiv mecarbil and rosuvastatin, a BCRP substrate, with a clinical study in healthy subjects and using a physiologically-based pharmacokinetic model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ashit Trivedi Research Topics

Disease

18	Heart Failure 01/2023 - 01/2021
4	Tuberculosis (Tuberculoses) 01/2019 - 10/2012
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 02/2024
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2021
1	Infections 01/2018
1	Extensively Drug-Resistant Tuberculosis 02/2014

Drug/Important Bio-Agent (IBA)

13	omecamtiv mecarbilIBA 01/2022 - 01/2021
12	Cardiac MyosinsIBA 01/2022 - 01/2021
4	Apelin ReceptorsIBA 01/2023 - 03/2022
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 02/2014
1	avacopanIBA 02/2024
1	AutoantibodiesIBA 02/2024
1	Anaphylatoxin C5a ReceptorIBA 02/2024
1	Cytochrome P-450 CYP3AIBA 01/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022
1	TabletsIBA 01/2022
1	Rosuvastatin Calcium (Crestor)FDA Link 11/2021
1	CytokinesIBA 01/2018
1	Spectinomycin (Spectinomycin Hydrochloride)FDA Link 02/2014
1	Bacterial Proteins (Bacterial Protein)IBA 02/2014
1	Antitubercular AgentsIBA 10/2012

Therapy/Procedure

1	Drug Tapering 01/2022
1	Drug Therapy (Chemotherapy) 01/2018
1	Therapeutics 02/2014